Zhenqiang Yao

5.1k total citations · 1 hit paper
48 papers, 4.0k citations indexed

About

Zhenqiang Yao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhenqiang Yao has authored 48 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 33 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Zhenqiang Yao's work include Bone Metabolism and Diseases (37 papers), Bone health and treatments (27 papers) and NF-κB Signaling Pathways (14 papers). Zhenqiang Yao is often cited by papers focused on Bone Metabolism and Diseases (37 papers), Bone health and treatments (27 papers) and NF-κB Signaling Pathways (14 papers). Zhenqiang Yao collaborates with scholars based in United States, China and United Kingdom. Zhenqiang Yao's co-authors include Brendan F. Boyce, Lianping Xing, Edward M. Schwarz, Qian Zhang, Yan Xiu, I.R. Badell, Ian C. Locke, Stephen J. Getting, Jinbo Li and Jinbo Li and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Zhenqiang Yao

48 papers receiving 4.0k citations

Hit Papers

Regulation of TNF-Induced Osteoclast Differentiation 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenqiang Yao United States 30 2.6k 1.4k 759 717 679 48 4.0k
Haibo Zhao United States 39 2.9k 1.1× 1.3k 0.9× 654 0.9× 346 0.5× 563 0.8× 94 4.4k
Jean‐Pierre David Germany 30 2.8k 1.1× 1.4k 0.9× 740 1.0× 884 1.2× 405 0.6× 48 4.2k
Xu Feng United States 33 4.0k 1.5× 2.1k 1.5× 835 1.1× 683 1.0× 943 1.4× 80 5.9k
Noriyoshi Kurihara United States 37 2.4k 0.9× 2.2k 1.5× 494 0.7× 664 0.9× 580 0.9× 106 4.3k
Xijie Yu China 37 2.4k 0.9× 1.0k 0.7× 624 0.8× 1.0k 1.5× 653 1.0× 131 5.2k
Masamichi Takami Japan 33 3.4k 1.3× 2.0k 1.4× 820 1.1× 861 1.2× 647 1.0× 110 4.9k
Yoshiyuki Hakeda Japan 43 3.4k 1.3× 2.0k 1.4× 739 1.0× 771 1.1× 735 1.1× 89 5.4k
Silvia Hayer Austria 33 2.3k 0.9× 1.2k 0.8× 622 0.8× 1.8k 2.5× 590 0.9× 80 4.1k
Simone Cenci Italy 30 2.6k 1.0× 1.2k 0.8× 344 0.5× 289 0.4× 644 0.9× 67 4.1k
Roberta Faccio United States 39 2.9k 1.1× 2.0k 1.4× 763 1.0× 332 0.5× 432 0.6× 86 4.8k

Countries citing papers authored by Zhenqiang Yao

Since Specialization
Citations

This map shows the geographic impact of Zhenqiang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenqiang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenqiang Yao more than expected).

Fields of papers citing papers by Zhenqiang Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenqiang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenqiang Yao. The network helps show where Zhenqiang Yao may publish in the future.

Co-authorship network of co-authors of Zhenqiang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenqiang Yao. A scholar is included among the top collaborators of Zhenqiang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenqiang Yao. Zhenqiang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Duan, Rong, Philip Milton, Chutamath Sittplangkoon, et al.. (2024). Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy. Cancer Immunology Immunotherapy. 73(10). 203–203. 4 indexed citations
3.
Yao, Zhenqiang, Xin Liu, Rong Duan, et al.. (2023). TGFβ1+CCR5+ neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice. Nature Communications. 14(1). 159–159. 26 indexed citations
4.
Yao, Zhenqiang & Brendan F. Boyce. (2022). TGFβ priming promotes TNF-induced bone erosion: a promising new target in RA?. Nature Reviews Rheumatology. 18(11). 617–618. 1 indexed citations
5.
Yao, Zhenqiang, Lianping Xing, & Brendan F. Boyce. (2020). RANKL-Based Osteoclastogenic Assay from Murine Bone Marrow Cells. Methods in molecular biology. 457–465. 1 indexed citations
6.
Sun, Shuting, Jianguo Tao, Parish P. Sedghizadeh, et al.. (2020). Bisphosphonates for delivering drugs to bone. British Journal of Pharmacology. 178(9). 2008–2025. 29 indexed citations
7.
Li, Jinbo, Yan Xiu, James O. Sanders, et al.. (2019). TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis. Nature Communications. 10(1). 2795–2795. 70 indexed citations
8.
Wang, Shengli, Shuguang Zuo, Zhigang Liu, et al.. (2018). Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis. Biomedicine & Pharmacotherapy. 106. 813–820. 27 indexed citations
9.
Yao, Zhenqiang, Wei Lei, Rong Duan, et al.. (2017). RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors. Journal of Biological Chemistry. 292(24). 10169–10179. 54 indexed citations
10.
Krieger, Nancy S., Zhenqiang Yao, Kelly Kyker‐Snowman, et al.. (2016). Increased bone density in mice lacking the proton receptor OGR1. Kidney International. 89(3). 565–573. 33 indexed citations
11.
Boyce, Brendan F., Zhenqiang Yao, & Lianping Xing. (2010). Functions of nuclear factor κB in bone. Annals of the New York Academy of Sciences. 1192(1). 367–375. 143 indexed citations
12.
Boyce, Brendan F., Zhenqiang Yao, & Lianping Xing. (2009). Osteoclasts Have Multiple Roles in Bone in Addition to Bone Resorption. Critical Reviews in Eukaryotic Gene Expression. 19(3). 171–180. 147 indexed citations
13.
Yao, Zhenqiang, Lianping Xing, Chunlin Qin, Edward M. Schwarz, & Brendan F. Boyce. (2008). Osteoclast Precursor Interaction with Bone Matrix Induces Osteoclast Formation Directly by an Interleukin-1-mediated Autocrine Mechanism. Journal of Biological Chemistry. 283(15). 9917–9924. 88 indexed citations
14.
Yamashita, Teruhito, Zhenqiang Yao, Fang Li, et al.. (2007). NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1. Journal of Biological Chemistry. 282(25). 18245–18253. 366 indexed citations
15.
Zhang, Qian, Yan Lu, Steven T. Proulx, et al.. (2007). Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Research & Therapy. 9(6). R118–R118. 130 indexed citations
16.
Boyce, Brendan F., Zhenqiang Yao, Qian Zhang, et al.. (2007). New Roles for Osteoclasts in Bone. Annals of the New York Academy of Sciences. 1116(1). 245–254. 27 indexed citations
17.
Morello, Roy, Terry Bertin, Yuqing Chen, et al.. (2006). CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta. Cell. 127(2). 291–304. 366 indexed citations
18.
Yao, Zhenqiang, Ping Li, Qian Zhang, et al.. (2006). Tumor Necrosis Factor-α Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression. Journal of Biological Chemistry. 281(17). 11846–11855. 167 indexed citations
19.
Boyce, Brendan F., Lianping Xing, Zhenqiang Yao, et al.. (2006). Future Anti‐Catabolic Therapeutic Targets in Bone Disease. Annals of the New York Academy of Sciences. 1068(1). 447–457. 18 indexed citations
20.
Li, Ping, Zhenqiang Yao, Qian Zhang, et al.. (2005). TNF.ALPHA. and pathologic bone resorption. The Keio Journal of Medicine. 54(3). 127–131. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026